Application Sponsors
ANDA 216204 | AUROBINDO PHARMA LTD | |
Marketing Status
Application Products
001 | TABLET;ORAL | 38MG;200MG | 0 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | DIPHENHYDRAMINE CITRATE; IBUPROFEN |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-05-31 | STANDARD |
Submissions Property Types
CDER Filings
AUROBINDO PHARMA LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 216204
[companyName] => AUROBINDO PHARMA LTD
[docInserts] => ["",""]
[products] => [{"drugName":"IBUPROFEN AND DIPHENHYDRAMINE CITRATE","activeIngredients":"DIPHENHYDRAMINE CITRATE; IBUPROFEN","strength":"38MG;200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"05\/31\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-05-31
)
)